APA

Inwards D. J., Fishkin P. A., LaPlant B. R., Drake M. T., Kurtin P. J., Nikcevich D. A., Wender D. B., Lair B. S. & Witzig T. E. (022019). Phase I trial of rituximab, cladribine, and temsirolimus (RCT) for initial therapy of mantle cell lymphoma. : Annals of oncology : official journal of the European Society for Medical Oncology.

Chicago

Inwards D J, Fishkin P A, LaPlant B R, Drake M T, Kurtin P J, Nikcevich D A, Wender D B, Lair B S and Witzig T E. 022019. Phase I trial of rituximab, cladribine, and temsirolimus (RCT) for initial therapy of mantle cell lymphoma. : Annals of oncology : official journal of the European Society for Medical Oncology.

Harvard

Inwards D. J., Fishkin P. A., LaPlant B. R., Drake M. T., Kurtin P. J., Nikcevich D. A., Wender D. B., Lair B. S. and Witzig T. E. (022019). Phase I trial of rituximab, cladribine, and temsirolimus (RCT) for initial therapy of mantle cell lymphoma. : Annals of oncology : official journal of the European Society for Medical Oncology.

MLA

Inwards D J, Fishkin P A, LaPlant B R, Drake M T, Kurtin P J, Nikcevich D A, Wender D B, Lair B S and Witzig T E. Phase I trial of rituximab, cladribine, and temsirolimus (RCT) for initial therapy of mantle cell lymphoma. : Annals of oncology : official journal of the European Society for Medical Oncology. 022019.